The very sick feeling in my stomach I am getting right now is the thought that there are several people who bought $40+ that are still holding out hope. BTW, I take no glee out of DNDN's demise. I own several immunotherapy stocks. DNDN story is just a major fckup of executive leadership.
Technical analysts would call the monthly chart in DNDN a "Tombstone Formation".